1-3 of 3
Kaylin Marie McMahon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Investigations of Redox Resistance in Aggressive Lymphomas with Cholesterol Modulating Lipid Nanoparticles

Meiying Yang, Jonathan Scott Rink, Shuo Yang, Eva Yang, Kaylin Marie McMahon, Colby Shad Thaxton, Leo I. Gordon, Adam Yuh Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 5993–5994.
https://doi.org/10.1182/blood-2022-168394
Published: 2022
Journal Articles

Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO)

Jonathan Rink, PhD, Osman Cen, PhD, Kaylin Marie McMahon, PhD, Sol Misener, BS, Shuo Yang, PhD, Colby Shad Thaxton, MD PhD, Leo I. Gordon, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 576.
https://doi.org/10.1182/blood.V130.Suppl_1.576.576
Published: 2017
Journal Articles

Synthetic High-Density Lipoprotein-like Nanoparticles (HDL NP) Cause Apoptosis and Enhance Killing By B-Cell Receptor and BCL-2 Inhibitors in Chronic Lymphocytic Leukemia (CLL)

Kaylin Marie McMahon, Cristina Scielzo, Lydia Scarfo, Pamela Ranghetti, Shuo Yang, Leo I. Gordon, MD, Frank Giles, MDMB, Colby Shad Thaxton, MD PhD, Paolo Ghia, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2949.
https://doi.org/10.1182/blood.V126.23.2949.2949
Published: 2015